Castle Biosciences CSTL Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's free cash flow?
- Castle Biosciences (CSTL) reported free cash flow of -$34.58M in Q1 2026.
- How has Castle Biosciences's free cash flow changed year-over-year?
- Castle Biosciences's free cash flow decreased by 220.9% year-over-year, from -$10.78M to -$34.58M.
- What is the long-term trend for Castle Biosciences's free cash flow?
- Over 3 years (2021 to 2025), Castle Biosciences's free cash flow has grown at a 8.0% compound annual growth rate (CAGR), from -$22.47M to $28.33M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.